Back to Search Start Over

Design of bioactive peptides derived from CART sequence isolated from the toadfish Thalassophryne nattereri .

Authors :
Conceição K
de Cena GL
da Silva VA
de Oliveira Neto XA
de Andrade VM
Tada DB
Richardson M
de Andrade SA
Dias SA
Castanho MARB
Lopes-Ferreira M
Source :
3 Biotech [3 Biotech] 2020 Apr; Vol. 10 (4), pp. 162. Date of Electronic Publication: 2020 Mar 06.
Publication Year :
2020

Abstract

The emergence of bacterial resistance due to the indiscriminate use of antibiotics warrants the need for developing new bioactive agents. In this context, antimicrobial peptides are highly useful for managing resistant microbial strains. In this study, we report the isolation and characterization of peptides obtained from the venom of the toadfish Thalassophryne nattereri . These peptides were active against Gram-positive and Gram-negative bacteria and fungi . The primary amino acid sequences showed similarity to Cocaine and Amphetamine Regulated Transcript peptides, and two peptide analogs-Tn CRT2 and Tn CRT3-were designed using the AMPA algorithm based on these sequences. The analogs were subjected to physicochemical analysis and antimicrobial screening and were biologically active at concentrations ranging from 2.1 to 13 µM. Zeta potential analysis showed that the peptide analogs increased the positive charge on the cell surface of Gram-positive and Gram-negative bacteria. The toxicity of Tn CRT2 and Tn CRT3 were analyzed in vitro using a hemolytic assay and tetrazolium salt reduction in fibroblasts and was found to be significant only at high concentrations (up to 40 µM). These results suggest that this methodological approach is appropriate to design novel antimicrobial peptides to fight bacterial infections and represents a new and promising discovery in fish venom.<br />Competing Interests: Conflict of interestThe authors declare no conflict of interest.<br /> (© King Abdulaziz City for Science and Technology 2020.)

Details

Language :
English
ISSN :
2190-572X
Volume :
10
Issue :
4
Database :
MEDLINE
Journal :
3 Biotech
Publication Type :
Report
Accession number :
32206496
Full Text :
https://doi.org/10.1007/s13205-020-2151-4